Market Place
Sourcing Support
Caplin`s Generic Ketorolac Tromethamine Receives Approval in the U.S.
26 Mar 2024 //
FDA
Enforcement Report - Week of December 6, 2023
06 Dec 2023 //
FDA
Aspiro`s Generic (Ketorolac Tromethamine) Receives Approval in the U.S.
20 Jun 2023 //
FDA
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
USFDA approves Alembic’s Ketorolac tromethamine injection USP
03 Nov 2022 //
ECONOMICTIMES
Alembic`s Generic Ketorolac Tromethamine Receives Approval in the U.S.
02 Nov 2022 //
FDA
FDA warns US sterile injectable maker on contamination controls,another US maker
28 Oct 2022 //
RAPS
Zydus` Generic Ketorolac Tromethamine Receives Approval in the U.S.
21 Oct 2022 //
FDA
Hetero`s Generic Ketorolac Tromethamine Receives Approval in the U.S.
25 Aug 2022 //
FDA
Enforcement Report - Week of August 24, 2022
24 Aug 2022 //
FDA
Havix`s Generic Ketorolac Tromethamine Receives Approval in the U.S.
23 Mar 2022 //
FDA
Fresenius Kabi pulls anti-inflammation drug Ketorolac over particulate fears
21 Jan 2021 //
FIERCEPHARMA
Recall report: Fresenius Kabi yanks inflammatory med Ketorolac after finding
11 Jan 2021 //
ENDPTS
Enforcement Report - Week of January 6, 2021
06 Jan 2021 //
FDA
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
22 Dec 2020 //
PRNEWSWIRE
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
22 Dec 2020 //
PRNEWSWIRE
Neumentum & Nuance Biotech Enter into Licensing Agreement for NTM-001
21 Oct 2020 //
GLOBENEWSWIRE
Nephron`s Generic Ketorolac Tromethamine Receives Approval In US
20 Aug 2020 //
FDA
Enforcement Report - Week of June 17, 2020
17 Jun 2020 //
FDA
CORRECTING & REPLACING CAPTIONS Fresenius Kabi Issues Nationwide Recall
20 Apr 2020 //
BUSINESSWIRE
Enforcement Report - Week of February 19, 2020
20 Feb 2020 //
FDA
Promising Results From Human PK Study Assessing Novel Ketorolac Formulations
29 Jan 2020 //
PR NEWSWIRE
Union Quimico Farmaceutica Fails EDQM Inspection
29 Oct 2019 //
EDQM
J&J offloads midphase pain program to Neumentum
10 Oct 2019 //
FIERCE BIOTECH
Sagent Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection
30 Apr 2019 //
PR NEWSWIRE
Micro Labs India Generic Ketorolac Tromethamine Receives Approval in US
09 Apr 2019 //
FDA
Enforcement Report for Week of February 20, 2019
20 Feb 2019 //
FDA
JCB Laboratories Receives Form 483
26 Nov 2018 //
FDA
Aurobindo Pharma` Generic Ketorolac Tromethamine Receives Approval in US
22 Nov 2018 //
FDA
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
Neumentum Announces Dosing in Phase I Study Evaluating NTM-001, a Non-Opioid
06 Sep 2018 //
PR NEWSWIRE
Ketamine emerging as a popular treatment for depression; but…
29 Aug 2018 //
CNBC
Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets
29 Aug 2018 //
BUSINESSWIRE
Cycle Pharms` Generic Ketorolac Tromethamine Receives Approval in US
22 Aug 2018 //
FDA
Sandoz Amends ANDA to Not Seek Approval for Generic Version of OMIDRIA
26 Jul 2018 //
BUSINESSWIRE
Omeros Corporation Initiates Sales of OMIDRIA in Europe
23 Jul 2018 //
BUSINESSWIRE
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX®
07 May 2018 //
PR NEWSWIRE
Egalet`s Partner OraPharma Begins Promotion of SPRIX® Nasal Spray
23 Jan 2018 //
PR NEWSWIRE
Enforcement Report - Week of January 17, 2018
17 Jan 2018 //
FDA
Egalet, OraPharma to co-promote Sprix nasal spray in US market
04 Jan 2018 //
PHARMABIZ
Enforcement Report - Week of October 4, 2017
04 Oct 2017 //
FDA
Cycle Pharma Receives FDA Approval & Launches Ketorolac Tromethamine Injection
20 Sep 2017 //
BUSINESSWIRE
Cycle Pharma Receives FDA Approval & Launches Ketorolac Tromethamine Inj 30mg/Ml
19 Sep 2017 //
BUSINESSWIRE
Cycle Pharm’s Generic Ketorolac Tromethamine Receives Approval In US
18 Sep 2017 //
FDA
Enforcement Report - Week of September 6, 2017
06 Sep 2017 //
FDA
Omeros looks to raise $70M in stock offering to fuel drug development pipeline
16 Aug 2017 //
GEEK WIRE
Egalet Receives FDA Approval for Extended-Release Product
17 Jan 2017 //
DRUG DEVELOPMENT
Anti-inflammatory pills tied to heart failure risk
21 Oct 2016 //
REUTERS
Egalet Settles Patent Litigations with Purdue Pharma
23 May 2016 //
PR NEWSWIRE
